𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NOX enzymes as novel targets for drug development

✍ Scribed by J. David Lambeth; Karl-Heinz Krause; Robert A. Clark

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
472 KB
Volume
30
Category
Article
ISSN
1863-2297

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hsp90 as a Target for Drug Development
Hsp90 as a Target for Drug Development
✍ Subhabrata Chaudhury; Timothy R. Welch; Brian S. J. Blagg πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons βš– 11 KB
Hsp90 as a Target for Drug Development
Hsp90 as a Target for Drug Development
✍ Subhabrata Chaudhury; Timothyβ€…R. Welch; Brianβ€…S.β€…J. Blagg πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 605 KB
GABA receptors and GABAergic synapses as
GABA receptors and GABAergic synapses as targets for drug development
✍ Charles P. Taylor πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 695 KB

Gamma-amino butyric acid (GABA) is perhaps the most abundant and important rapid inhibitory neurotransmitter in the mammalian brain. Many previous studies have indicated that GABAergic synapses are involved in drug treatments or disease processes for epilepsy, anxiety, movement disorders, depression

Magnetic Sephadex as a carrier for enzym
Magnetic Sephadex as a carrier for enzyme immobilization and drug targeting
✍ Torchilin, V. P. ;Papisov, M. I. ;Smirnov, V. N. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 491 KB

Magnetic materials were suggested as carriers for protein immobilization about 10 years ago [1,2]. The main advantage of these carriers is their ability to be concentrated near magnetic terminals upon the application of the external magnetic field. This property is used in technological processes fo